Pressure BioSciences, Inc. (PBIO) is Making the Right Steps as Scientists and Research Firms Around the Nation Take Notice
Pressure BioSciences has continued to add research and development personnel to its staff to expand the number, as well as the scope, of R&D projects underway. The Company anticipates that its increased investments in R&D will complement its commercialization efforts by encouraging the continued publication of application notes in areas currently using PCT technology and creating new inventions that rely on its PCT technology. The Company recently announced that a study focused on the discovery and identification of potential biomarkers of colon cancer was presented at the Annual Scientific Meeting of the American College of Gastroenterology (ACG). The study specifically…